Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / DOVA - Moore Kuehn PLLC Encourages Milacron Holdings Corp. (MCRN) Ecology & Environmental Inc. (EEI) Pivotal Software Inc. (PVTL) and Dova Pharmaceuticals Inc. (DOVA) Investors to Contact Firm


DOVA - Moore Kuehn PLLC Encourages Milacron Holdings Corp. (MCRN) Ecology & Environmental Inc. (EEI) Pivotal Software Inc. (PVTL) and Dova Pharmaceuticals Inc. (DOVA) Investors to Contact Firm

NEW YORK, Oct. 17, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations of law related to the following companies' entry into merger agreements:

Milacron Holdings Corp. (NYSE: MCRN)

Milacron has agreed to be acquired by Hillenbrand, Inc. Under the terms of the proposed transaction shareholders of Milacron will receive $11.80 and 0.1612 shares of Hillenbrand for every share of Milacron stock owned.

Ecology & Environmental, Inc. (NASDAQ: EEI)

Ecology & Environmental has agreed to be acquired by WSP Global, Inc. Under the terms of the proposed transaction shareholders of Ecology & Environmental will receive $15.00 in cash and a special dividend up to $0.50 in chase for every share of Ecology & Environmental stock owned.

Pivotal Software, Inc. (NYSE: PVTL)

Pivotal Software has agreed to be acquired by VMware, Inc. Under the terms of the proposed transaction shareholders of Pivotal will receive $15.00 for every share of Pivotal Software stock owned.

Dova Pharmaceuticals, Inc. (NASDAQ: DOVA)

Dova may be sold to Swedish Orphan Biovitrum AB. Under the terms of the proposed transaction, shareholders of Dova will receive an upfront payment for $27.50 per share in cash and one non-tradeable Contingent Value Right to an additional $1.50 per share in cash upon regulatory approval of DOPTELET.

Moore Kuehn is investigating whether the Boards of MCRN, EEI, PVTL, and DOVA 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process. Moore Kuehn may ultimately seek an increased share price, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies.

Moore Kuehn encourages shareholders to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com or telephone at (212) 709-8245. There is no cost or obligation to you.

Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please go to http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
jkuehn@moorekuehn.com
(212) 709-8245

SOURCE Moore Kuehn, PLLC

Stock Information

Company Name: Dova Pharmaceuticals Inc.
Stock Symbol: DOVA
Market: NASDAQ
Website: dova.com

Menu

DOVA DOVA Quote DOVA Short DOVA News DOVA Articles DOVA Message Board
Get DOVA Alerts

News, Short Squeeze, Breakout and More Instantly...